- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Aridis Pharmaceuticals Stock (NASDAQ:ARDS), Quotes and News Summary
Aridis Pharmaceuticals Stock (NASDAQ: ARDS)
| Day Range0.89 - 0.95 | 52 Wk Range0.68 - 2.94 | Open / Close0.9 / 0.93 | Float / Outstanding16.3M / 17.7M |
| Vol / Avg.125.6K / 192.7K | Mkt Cap16.5M | P/E- | 50d Avg. Price1.67 |
| Div / Yield- | Payout Ratio- | Total Float16.3M | EPS-0.45 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-09 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.060 | -0.450 | -0.3900 | ||||
| REV | 10.460M | 292.000K | -10.168M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Aridis Pharmaceuticals Questions & Answers
You can purchase shares of Aridis Pharmaceuticals (NASDAQ: ARDS) through any online brokerage.
Other companies in Aridis Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Biocept (NASDAQ:BIOC), Brooklyn (NASDAQ:BTX), Humanigen (NASDAQ:HGEN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for Aridis Pharmaceuticals (NASDAQ: ARDS) was reported by Maxim Group on Tuesday, August 16, 2022. The analyst firm set a price target for 0.00 expecting ARDS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Aridis Pharmaceuticals (NASDAQ: ARDS) is $0.93 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aridis Pharmaceuticals.
Aridis Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Aridis Pharmaceuticals.
Aridis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.